Skip to content
← Back to this collection

PUBLICATIONS · 18309945

Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2008 Mar 1
First author
Barry EV

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Barry EV
      type
      Author
    2. name
      Vrooman LM
      type
      Author
    3. name
      Dahlberg SE
      type
      Author
    4. name
      Neuberg DS
      type
      Author
    5. name
      Asselin BL
      type
      Author
    6. name
      Athale UH
      type
      Author
    7. name
      Clavell LA
      type
      Author
    8. name
      Larsen EC
      type
      Author
    9. name
      Moghrabi A
      type
      Author
    10. name
      Samson Y
      type
      Author
    11. name
      Schorin MA
      type
      Author
    12. name
      Cohen HJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Barry EV
      type
      Author
    2. name
      Vrooman LM
      type
      Author
    3. name
      Dahlberg SE
      type
      Author
    4. name
      Neuberg DS
      type
      Author
    5. name
      Asselin BL
      type
      Author
    6. name
      Athale UH
      type
      Author
    7. name
      Clavell LA
      type
      Author
    8. name
      Larsen EC
      type
      Author
    9. name
      Moghrabi A
      type
      Author
    10. name
      Samson Y
      type
      Author
    11. name
      Schorin MA
      type
      Author
    12. name
      Cohen HJ
      type
      Author
    bibliography ids
    1. nci-bib-45e8c6c135ddb63011877e64
    book metadata
    content sha256
    407911c8ee93a7ae6c5c2f55db48c923b120877376f8c11773b228e513c35dbc
    document type
    citation
    dois
    1. 10.1200/JCO.2007.12.2481
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:18309945
    immutable id
    pubmed:18309945@407911c8ee93a7ae6c5c2f55db48c923b120877376f8c11773b228e513c35dbc
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    7
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    1106-11
    volume
    26
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      18309945
      provenance
      batch id
      e663b4be92ee60a9b059
      provider
      NCBI PubMed ESummary
      record sha256
      b3e05bf459e0871989a7d697d394288025c3fbfa8f7a7b6c29ea71860aa17527
      response sha256
      514286e846d1566a3f75c88a4af66b82adfc16ee2368b19bce657f2237aba90d
      retrieved at
      2026-09-09T23:46:19.265979+00:00
      publication date
      display
      2008 Mar 1
      precision
      day
      year
      2008
      publication types
      1. Journal Article
      2. Multicenter Study
      3. Randomized Controlled Trial
      4. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/18309945/
      title
      Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane.

      Preserved source evidence · Not medical advice